SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-003617
Filing Date
2020-01-14
Accepted
2020-01-14 07:05:23
Documents
3
Period of Report
2020-01-14
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm203341d1_8k.htm 8-K 17543
2 EXHIBIT 99.1 tm203341d1_ex99-1.htm EX-99.1 18553
3 GRAPHIC tm203341d1_ex99-1img01.jpg GRAPHIC 4422
  Complete submission text file 0001104659-20-003617.txt   43574
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31918 | Film No.: 20524945
SIC: 2836 Biological Products, (No Diagnostic Substances)